Gupta Rishi [Rocket]

Date	Name	Symbol	Type	Security	Shares	Price	Value	Ownership	Reported
05/17/2023	Enliven Therapeutics, Inc.	IMRA	Exercise	Stock Options (Right to Buy)	2.1k	$4.28	$9.1k	See footnotes	05/17/2023
05/15/2023	Verona Pharma plc	VRNA	Sale	Ordinary Shares	345.3k	$20.00	$6.9M	See footnotes	05/11/2023
05/15/2023	Verona Pharma plc	VRNA	Sale	Ordinary Shares	14.4k	$21.96	$316.2k	See footnotes	05/11/2023
05/12/2023	Verona Pharma plc	VRNA	Sale	Ordinary Shares	43.2k	$21.64	$934.8k	See footnotes	05/11/2023
05/11/2023	Verona Pharma plc	VRNA	Sale	Ordinary Shares	80k	$22.26	$1.8M	See footnotes	05/11/2023
04/28/2023	Verona Pharma plc	VRNA	Grant	Share Options (Right to Buy)	96k	$0.00	$0		04/28/2023
02/23/2023	Enliven Therapeutics, Inc.	IMRA	Grant	Common Stock	7.6M	$0.00	$0	See footnote	02/23/2023
02/23/2023	Enliven Therapeutics, Inc.	IMRA	Grant	Common Stock	288.1k	$0.00	$0	See footnote	02/23/2023
04/28/2022	Verona Pharma plc	VRNA	Grant	Share Options (Right to Buy)	200k	$0.00	$0		04/28/2022
08/09/2021	Verona Pharma plc	VRNA	Grant	Share Options (Right to Buy)	64k	$0.00	$0		08/09/2021
05/19/2016	Dimension Therapeutics, Inc.	DMTX	Grant	Stock Option (Right to Buy)	32.1k	$7.08	$227k		05/19/2016
10/27/2015	Dimension Therapeutics, Inc.	DMTX	Conversion	Series B Preferred Stock	5.7M	$0.00	$0	See Footnotes	10/27/2015
10/27/2015	Dimension Therapeutics, Inc.	DMTX	Conversion	Series A Preferred Stock	9.5M	$0.00	$0	See Footnotes	10/27/2015
10/27/2015	Dimension Therapeutics, Inc.	DMTX	Purchase	Common Stock	200k	$13.00	$2.6M	See Footnotes	10/27/2015
10/27/2015	Dimension Therapeutics, Inc.	DMTX	Conversion	Common Stock	1.9M	$0.00	$0	See Footnotes	10/27/2015
10/27/2015	Dimension Therapeutics, Inc.	DMTX	Conversion	Common Stock	3.3M	$0.00	$0	See Footnotes	10/27/2015